Percutaneous nephrolithotomy (PCNL) is a surgical procedure used to remove kidney stones that are too large to pass on their own. When less-invasive treatments are ineffective or not feasible, this method is typically recommended by healthcare providers. It involves creating a small passageway through the skin on the back to access the kidney and remove the stones.
During the procedure, a surgeon inserts specialized instruments through a tiny tube into the kidney to locate and extract the stones. This direct approach is often chosen for larger stones that can’t be removed through less invasive techniques. By creating a targeted passageway, the surgeon can efficiently reach and remove the problematic stones.
Although PCNL is considered a minimally invasive surgery, it is still a significant operation. It offers a faster recovery and fewer complications than open surgery, making it a preferred option in many cases. However, it remains a major surgical intervention, and careful consideration is given to its necessity based on the patient’s specific condition.
Most kidney stones pass naturally without the need for surgery. However, percutaneous nephrolithotomy may be recommended for patients with stones that are too large to be treated by other methods or when passing the stone naturally is not possible, particularly in the following cases:
Although percutaneous nephrolithotomy is a minimally invasive procedure, it still carries several risks, including:
Before the procedure, a comprehensive health assessment will be scheduled, which will include checking vital signs such as temperature, pulse, and blood pressure. To obtain a clearer view of the kidney stone, the healthcare provider may request imaging tests such as a computed tomography (CT) scan, ultrasound, or X-ray prior to surgery. Urine and blood tests may also be required to check for infections or other issues.
It is crucial to inform the healthcare provider about the following:
The healthcare provider may also recommend the following before the procedure:
Percutaneous nephrolithotomy is typically performed in a hospital setting under general anesthesia, ensuring the patient is not awake and feels no pain. One usually lies on their stomach, though they may be positioned on their back with or without a cushion.
The procedure is done as follows:
As the anesthesia wears off, one will regain consciousness but may feel groggy. In the recovery room, healthcare providers will monitor the patient, manage their pain, and ensure they are recovering properly.
It is normal for the patient to have a small amount of blood in their urine for one to two weeks after the surgery. However, those with drainage tubes left in the kidney should monitor for any signs of bleeding. Seek medical attention if any of the following is experienced:
Typically, the patient will stay in the hospital for a day for observation. Heavy lifting or strenuous activities for 2 to 4 weeks should be avoided. They may be able to return to work after about a week.
After undergoing percutaneous nephrolithotomy, patients may need blood tests to identify the cause of the kidney stones and discuss strategies for preventing future stones. A follow-up visit with the surgeon is typically scheduled 4 to 6 weeks after the surgery, or sooner if a nephrostomy tube is in place. If a nephrostomy tube is present, it will be removed by the healthcare provider using local anesthesia. During this follow-up visit, imaging tests such as ultrasound, X-ray, or CT scan may also be performed to ensure that no stones remain, and that urine is draining properly.